Thriving in Failure

Le Bonheur cardiologists conduct first successful long-term use trial of platelet inhibitor cangrelor in pediatric patients on VADs

Le Bonheur radiologist pioneers novel imaging technique to match pediatric heart transplant recipients with donors

Cardiologists show heart damage in athletes unlikely after COVID-19 infection

The need for pediatric nephrologists to develop a special expertise in the onco-nephrology field is increasingly important as childhood cancer rates have been on the rise and new therapy protocols are advancing.

Eosinophils active in immediate defense during influenza a infection

Hospital embraces diversity, equity, inclusion effort

Each partner plays a unique role in the collaboration to provide comprehensive legal care for kids and families.

Le Bonheur endocrinologists seek to understand how race complicates diabetes

Manipulation of tumors based on molecular genetics began more than 35 years ago with shrinking prolactinomas before turning to neurosurgery.

While children infected with COVID-19 are less likely to develop severe illness compared to adults, not enough data exists to determine how they respond to various available treatments.

Le Bonheur named a "Best Children's Hospital" by "U.S. News & World Report" for 11th year

The latest news from Le Bonheur Children's